Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
32 Endovascular Interventions forMale Infertility
411
validation. Patients must undergo thorough evaluation to rule out non-vascular causes for ED (e.g. psychogenic, neurogenic, hormonal) before these procedures are considered.
7. Duplex USG is the rst-line imaging modality for
ED.
8. Angiography with angioplasty can be helpful in select cases. Patients with documented internal pudendal ste-
nosis and conrmed vascular aetiology for ED may ben­et from these interventions.
9. Retrograde venous occlusion is treatment option for
ED due to venous leak.
10. Outcomes from interventional procedures for ED vary widely. Patient selection, the underlying cause of
ED and technical aspects of the intervention can all inuence the outcomes. Continued research and assess­ment are needed to better dene the role of interven­tional radiology in management of ED.

References

1. Vilke GM, Harrigan RA, Ufberg JW, etal. Emergency evaluation of treatment of priapism. J Emerg Med. 2004;26:325–9.
2. Eland IA, van der Lei J, Stricker BJ, etal. Incidence of priapism in the general population. Adult Urol. 2001;57:970–2.
3. Montague DK, Jarow J, Broderick GA, etal. American Urological Association guideline on the management of priapism. J Urol. 2003;170:1918–24.
4. Savoca G, Pietropaolo F, Scieri F, etal. Sexual function after highly selective embolization of cavernous artery in patients with high­ow priapism: long-term follow-up. J Urol. 2004;172:644–7.
5. Hossein SN, Vikram D, Allen DS, et al. Priapism. Radiol Clin North Am. 2004;42:427–43.
6. Kim N, Vardi Y, Padma-Nathan H, etal. Oxygen tension regulates the nitric oxide pathway: physiological role in penile erection. J Clin Invest. 1993;91:437–42.
7. Langenhuijsen JF, Reisman Y, Reekers JA, de Reijke TM.Highly selective embolization of bilateral cavernous arteries for posttrau­matic penile arterial priapism. Int J Impot Res. 2001;13:354–6.
8. NIH Consensus Conference. Impotence. NIH consensus develop­ment panel on impotence. JAMA. 1993;270(1):83–90.
9. Schwartz BG, Kloner RA.Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation. 2011;123:98–101.
10. Javaroni V, Neves MF. Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment. Int J Hypertens. 2012;62:72–8.
11. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health profession­als follow-up study. Ann Intern Med. 2003;139:161–8.
12. Heidelbaugh JJ. Management of erectile dysfunction. Am Fam Physician. 2010;81:305–12.
13. Matn G. New treatments for erectile dysfunction. Fertil Steril. 2003;80:40–5.
14. Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: the management of erectile dysfunction: an AUA update. J Urol. 2005;174:230–9.
15. Valji K, Bookstein JJ. Transluminal angioplasty in the treat­ment of arteriogenic impotence. Cardiovasc Intervent Radiol. 1988;11:245–52.
16. Angelini P, Fighali S. Early experience with balloon angioplasty of internal iliac arteries for vasculogenic impotence. Catheter Cardiovasc Diagn. 1987;13:107–10.
17. Janssen T, Sarramon JP, Rischmann P, etal. Microsurgical arterio­arterial and arterio-venous penile revascularization in patients with pure arteriogenic impotence. Br J Urol. 1994;73:561–5.
18. Rosen MP, Schwartz AN, Levine FJ, Greeneld AJ.Radiologic assessment of impotence: angiography, sonography, cavernosog­raphy, and scintigraphy. AJR Am J Roentgenol. 1991;157:923–31.
19. Bilhim T, Casal D, Furtado A, et al. Branching patterns of the male internal iliac artery: imaging ndings. Surg Radiol Anat. 2011;33:151–9.
20. Delcour C, Wespes E, Vandenbosch G, etal. Impotence: evaluation with cavernosography. Radiology. 1986;161:803–6.
21. Suzuki K, Nishizawa S, Muraishi O, et al. Post-traumatic high­ow priapism: demonstrable ndings of penile enhanced computed tomography. Int J Urol. 2001;8:648–51.
22. Gufral S, MacDonagh RP, Cavanagh PM.Bilateral superselective arterial microcoil embolization in delayed post-traumatic high-ow priapism. Postgrad Med J. 2001;77:193–4.
23. Görich J, Ermis C, Krämer SC, et al. Interventional treatment of traumatic priapism. J Endovasc Ther. 2002;9:614–7.
24. Touge H, Watanabe T, Fujinaga T, Kawabata M. Post-traumatic high-ow priapism: a case report. Int J Urol. 1999;6:623–6.
25. Millward SF, Aquino J, Collins JP. High-ow priapism—recur­rence after initially successful selective coil embolization: case report. Can Assoc Radiol J. 1997;48:105–7.
26. Zumbé J, Drawz G, Wiedemann A, et al. Indications for penile revascularization and long-term results. Andrologia. 1999;31:83–7.
27. Basche S, Eger C, Elsebach K, Ulshofer B. Veno-occlusive dys­function as a cause of erectile impotence: therapy of venous leak with retrograde embolisation of the internal pudendal vein. Vasa. 2003;32:47–50.
28. Schild HH, Muller SC, Mildenberger P, Strunk H, Kalternborn H, Kersjes W, etal. Percutaneous penile venoablation for treatment of impotence. Cardiovasc Intervent Radiol. 1993;16:280–6.
29. Rebonato A, Auci A, Sanguinetti F, Maiettini D, Rossi M, Brunese L, etal. Embolization of the periprostatic venous plexus for erectile dysfunction resulting from venous leakage. JVIR. 2014;2014:01.015.
Part III
Non-vascular Interventions

Image-Guided Biopsy

NehaBaijal andS.H.Chandrashekhara
33
Key Messages
1. The use of image guidance improves the accuracy and safety of biopsy and almost any lesion which is visible on any modality can be sampled.
2. A thorough pre-procedure workup to assess indica­tions, contraindications, patient, and lesion suitability is essential to maximize yield and minimize complications.
3. A review of the available imaging is essential to identify the target lesion, choose the appropriate image guidance, and plan the approach and biopsy track.
4. In a case with multiple lesions, the most easily accessi­ble lesion with highest likely viable tissue yield and low­est risk of complications must be chosen.
5. The shortest path with minimal intervening normal tis­sue is generally the safest. This may be achieved by choosing the right image guidance, changing the patient position and various techniques like triangulation, com­pression, and hydrodissection.
6. The choice of biopsy device is based on size and loca­tion of the lesion, operator preference and cost.
7. Ultrasound is the most widely used modality for guid­ance due to its wide availability and real-time visualiza­tion capabilities. CEUS can be used to improve lesion conspicuity.
8. CT guidance provides access to areas where US conspi­cuity is limited by physics and anatomy, such as the lung, mediastinum, retroperitoneum, and bones.
9. MR guidance is used when both US and CT do not pro­vide adequate lesion visualization.
10. Recent advances include the use of CEUS, MRI, and fusion imaging to guide biopsies.

33.1 Introduction

While imaging alone can provide a diagnosis in many cases, histopathological conrmation is often required. Tissue sam­pling may be required in order to conrm a diagnosis, for immunohistochemical typing, to identify certain molecular markers for targeted therapy, and to conrm metastasis or recurrence of cancer.
Tissue sampling can be minimally invasive like ne­needle aspiration cytology (FNAC) and core biopsy; or sur­gical as in excisional biopsy. FNAC is the least invasive technique, well suited for small lesions (<1 cm in longest dimension), with the lowest risk of complications owing to the use of thin needles (typically 21G) (Fig.33.1). However, the amount of tissue obtained is limited, resulting in low sen­sitivity, high false negative rates, and the need for an on-site cytopathologist to conrm the adequacy of the sample in order to improve the yield. With the use of cell blocks, immu­nohistochemical information can be obtained even with FNAC; however, that too suffers from low sensitivity and high false negative rates.
a
b
N. Baijal Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, Delhi, India
S. H. Chandrashekhara ( Department of Radiodiagnosis and Interventional Radiology, IRCH, All India Institute of Medical Sciences, Delhi, India
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024 S. H. Chandrashekhara (ed.), Textbook of Interventional Radiology, https://doi.org/10.1007/978-981-97-9601-4_33
*)
Fig. 33.1 Commonly used FNAC needles. (a) Lumbar puncture nee- dle and (b) Chiba needle
415
416
N. Baijal and S. H. Chandrashekhara
Core biopsy can be done by percutaneous, endoluminal, or transvenous routes. Tissue cores ranging from 10 to 20mm can be obtained using different biopsy devices and guidance techniques. Imaging modalities used to guide biopsy procedures include ultrasound (US), contrast­enhanced ultrasound (CEUS), uoroscopy, mammography, computed tomography (CT), and magnetic resonance imag­ing (MRI). The choice of imaging modality used for guiding the biopsy depends on factors such as visibility of lesion, surrounding anatomy, and planned route of access. Other factors to consider include availability, cost, and radiation exposure.
The use of excisional biopsy is limited to cases in which surgery may be curative, risk of tract seeding from a percuta­neous biopsy is high, or when there would be no change in the surgical plan irrespective of the biopsy result.
In this chapter, we discuss various biopsy devices and techniques for performing an image-guided biopsy, includ­ing the pre-procedure workup, procedure, and post­procedure care. After a general discussion of the principles to be followed for US-, CT-, and MRI-guided biopsies, we then outline organ-specic and disease-specic considerations.

33.2 Biopsy Devices

There are several types of biopsy needles that differ in their length, caliber, tip, and mechanism of acquisition of the sam­ple. Selection of the biopsy device depends on various fac­tors such as the experience and preference of the interventional radiologist, the size and anatomical location of the lesion, surrounding structures in the planned biopsy tract, and the amount of tissue needed for biopsy [1].
Broadly speaking, there are two types of biopsy needles— aspiration and cutting needles.
Aspiration needles have beveled or circumferentially sharpened tips. Examples of aspiration needles with a bev­eled tip include Chiba (Cook Medical, Inc., Bloomington, IN) and spinal needles, which range from 20 to 23G and have a thin wall. Greene (Cook Medical, Inc., Bloomington, IN), Turner (Cook Medical, Inc., Bloomington, IN), and Franseen (Cook Medical, Inc., Bloomington, IN) needles are exam­ples of aspiration needles with a circumferentially sharpened tip. These are suitable for cytologic and microhistologic specimens [2].
Cutting needles are used to provide histologic specimens (Fig.33.2). The most commonly used sizes range from 18 to 20G for most organs while large-gauge needles such as 10G are used for musculoskeletal biopsies. Bone biopsy is done
a
b
c
Fig. 33.2 Schematic gure of biopsy procedure. (a) Biopsy needle is placed adjacent to target lesion. (b) The biopsy needle is pierced within the lesion. (c) Biopsy gun is red to obtain the tissue sample
using trephine and combination needles which include fea­tures of both cutting and trephine needles. Trephine needles include the 10G Craig (Becton, Dickinson and Company, Rutherford, NJ), the 12G Ackerman (Cook Medical, Inc., Bloomington, IN), and the Elson (Cook Medical, Inc), while combination needles include the Jamshidi (Manan Medical Products, Wheeling, IL), Ostycut (C.R. Bard, Covington, GA), and Osteosite (Cook Medical, Inc).
Depending on the location of the notch, cutting needles may be end- or side-cutting. End-cutting needles provide a cylindrical core of tissue by a sharpened hollow cannula which res over a stationary trocar. Side-cutting needles pro­vide a semi-cylindrical core by a beveled cannula that res over an inner stylet with a central notch.
Based on the ring mechanism, there are three kinds of biopsy devices—manual, semi-automatic, and automatic:
• Manual biopsy needles are used most commonly for bone
biopsies where the use of a combination of hammering
and a rotatory motion are required to advance the needle
through the bone.
• Semi-automatic biopsy devices have an outer guiding
needle and an inner stylet with a ring mechanism that
allows the stylet to be advanced rst and then red.
• Automatic biopsy devices have a rapid ring mechanism
which lowers the risk of needle deection, reduces patient
discomfort, and provides a larger amount of tissue with
minimal fragmentation. All end-cutting devices are fully
automated, while side-cutting devices can be manual,
semi-automatic, or automatic [3, 4].
33 Image-Guided Biopsy
417
The “coaxial technique” is the most commonly used tech­nique for image-guided biopsy, in which the outer guide needle is placed into the target tissue once and multiple cores can be taken by the inner needle without repeatedly travers­ing the entire path. This increases the tissue yield and also reduces the risk of complications such as bleeding. Advantages of this technique include reduced risk of injury to the surrounding tissue, reduced procedure time, reduced need for image guidance for each pass, and more secure access. After obtaining the sample, gel foam can be injected along the tract in order to minimize bleeding in highly vascu­lar organs like the liver. Similarly, post-biopsy pneumotho­rax can also be aspirated using the same access in case of CT-guided lung biopsy. The coaxial technique can also be used in manual biopsy devices. Radiofrequency ablation (RFA) of bone lesions like osteoid osteoma can be done in the same setting by placing the RFA probe through the outer cannula of the bone biopsy needle.
However, taking multiple cores from the same site lowers the tissue yield from subsequent passes. Various needle designs have been described in order to overcome this prob­lem. A side-exiting needle that can be rotated by 45 degrees after each pass has been described [5]. Curved inner needle is another modication that helps in taking samples from dif­ferent sites within the lesion [6].
Another limitation of the coaxial technique is that the inner needle is small in size and yields less amount of tissue. Detachable automatic biopsy devices have also been devel­oped to allow the outer cannula to function as a guide as well as the cutting needle [1].
In automatic biopsy devices, the inner needle and outer cutting sheath are red simultaneously. These needles are usually used without the coaxial technique. These devices provide a larger tissue yield in a single core such as in breast biopsy and are also useful in tissues that tend to “slip” during placement of the outer needle like the omentum. However, it is more traumatic as repeated punctures are required for mul­tiple passes, leading to an increased risk of complications and the risk of losing access. For most indications, semi­automatic biopsy guns with the coaxial technique are pre­ferred as they are less traumatic, provide better control over the access, and allow multiple passes and the instillation of any drug or embolizing agent through the outer cannula (Fig.33.3).
There are other devices for specic organs. One of them is vacuum-assisted biopsy used for breast lesions. It has a signicantly higher tissue yield than conventional core nee­dle biopsy and may even be curative for small lesions. Another special device is the transjugular liver biopsy set used for transvenous access in patients with uncorrectable coagulopathy or ascites.
ab
Fig. 33.3 Commonly used biopsy guns. (a) Automatic and (b) Semiautomatic biopsy guns

33.3 Pre-Procedural Evaluation

A review of the available imaging and laboratory investiga­tions should be done. The aim is to identify the lesion and its suitability for biopsy, plan the access, and choose the appro­priate technique. In a patient with multiple lesions, selection of the biopsy target should be based on the lowest risk and highest diagnostic yield. Based on the site of the lesion and planned access, risk of bleeding is assessed. Supercial structures like cervical lymph nodes, thyroid, breast, and soft tissue lesions in the extremities are considered to be at low risk of bleeding while intrathoracic and intra-abdominal pro­cedures carry a high bleeding risk. Further assessment should be done for bleeding risk due to patient factors such as thrombocytopenia, coagulopathy, liver disease, or pharma­cotherapy. Laboratory investigations including platelet count and PT-INR and the appropriate correction should be done as per the guidelines of the Society of Interventional Radiology (SIR), which is discussed in detail in Chap. 6.
Patients planned for intrathoracic and intra-abdominal biopsies are asked to report fasting for at least 6 hours. Patients planned for transrectal ultrasound (TRUS)-guided biopsies require bowel preparation for which laxatives are
418
administered one day prior to the procedure. In case transve­nous biopsy is planned, an ultrasound Doppler examination of the planned access site is necessary in order to rule out pre-existing thrombosis. Similarly, a screening USG of the planned target lesion should be done, ideally by the interven­tional radiologist who will be performing the biopsy, in order to identify the lesion and plan the best approach. If the lesion is not visible on USG, CT or MRI guidance may be required.
On the day of the planned biopsy, all regular medications, especially antihypertensives, should be taken. Insulin and oral anti-diabetic drugs may be omitted if the patient has been asked to report fasting in order to avoid hypoglycemia. Antiplatelets and anticoagulants are to be withheld as per SIR guidelines.
Written informed consent is essential and must be taken after explaining the risks and expected benets of the proce­dure to the patient. Intravenous access is secured prior to the procedure, preferably with at least a 20G cannula, in order to be able to administer medications in the event of an emer­gency such as a vasovagal reaction. The patient should be provided with a disposable gown and covered adequately to ensure patient comfort and privacy throughout the proce­dure. Patient positioning depends on the planned access. However, patient comfort must be ensured using pillows and sheets, as an uncomfortable patient is more likely to be uncooperative.
General complications of all biopsy procedures include pain, skin discomfort, bleeding, vasovagal syncope, infec­tion, and needle-tract seeding. Patients must be counseled regarding these general complications and any specic com­plications related to their disease prior to performing the procedure.

33.4 Ultrasound-Guided Biopsy

It is the most commonly used and widely available technique of image-guided biopsy (Fig.33.4). The biggest advantage of USG is the real-time visualization of the needle during the entire procedure, thereby increasing the safety and accuracy of the procedure. Other advantages include wide availability, low cost, and absence of radiation exposure. However, it is operator dependent and has a shallow learning curve as it requires the operator to coordinate the simultaneous use of the ultrasound probe and the needle with both hands. Also, USG has limited use in certain anatomic areas where US artifacts lead to poor visualization of the lesion such as the lung, mediastinum, bowel, retroperitoneum, and bones.
Any ultrasound probe that is appropriate for performing the diagnostic USG of the lesion can be used to guide a biopsy. For an intra-abdominal lesion, curvilinear transducer is used, while for supercial structures like the breast, linear
N. Baijal and S. H. Chandrashekhara
Fig. 33.4 Abdominal lymph node biopsy done using ultrasound guidance
transducer is used. TRUS is used for the prostate and trans­vaginal ultrasound (TVS) can be used for sampling vaginal, cervical, and adnexal lesions.
Patient positioning should be done so that both the patient
and operator are comfortable.
There are two techniques of guiding the needle using
USG:
• In-plane technique: As the name suggests, the needle is kept in the same plane as the ultrasound beam. This allows visualization of the entire length of the needle and is thus useful in critical areas such as the liver and kidney, where there is high risk of injury to surrounding structures.
• The out-of-plane technique is useful where there is less space for the probe to be placed, such as the neck. The needle and the ultrasound probe are kept perpendicular to each other and the cross-section of the needle is visible on USG.It is important to swipe the probe in order to con­rm the position of the needle tip prior to taking a biopsy. This technique is avoided in deep-seated structures as the entire length of the needle is not visible throughout the procedure.
Needle visualization may be difcult even with an in-
plane approach. In such cases, other techniques such as elec­tronic beam steering, injecting air into the coaxial needle, bouncing the needle with B-mode or Doppler USG, scoring the needle tip with a Kelly clamp, and turning off harmonic imaging for deeper lesions can help. The overall gain and time gain compensation settings should be optimized for the target lesion with the focal zone placed at the level of the lesion. For the biopsy of deep lesions, compression by the ultrasound probe reduces the abdominal wall thickness, dis-
33 Image-Guided Biopsy
419
places bowel loops, improves visualization of deeper struc­tures, shortens the needle path, and xes mobile masses [1,
7]. Color Doppler should be used to identify the location of
blood vessels around the site of biopsy in the organ being biopsied as well as in surrounding structures including the chest or abdominal wall [4].
Recently, CEUS has also been found useful to improve lesion conspicuity during biopsy, especially for isoechoic lesions in the liver and kidney. Standard amount of ultra­sound contrast agent (2.4 mL Sonovue) may be used just prior to the procedure or during the procedure. Sampling the most avidly enhancing part of the lesion is likely to yield viable tissue, while non-enhancing areas are more likely to be necrotic. CEUS guidance has been shown to improve lesion conspicuity and histopathologic yield of tissue in focal liver lesions, as well as breast lesions that are poorly visual­ized on grayscale USG [8, 9]. Case series have also shown that CEUS guidance improves the yield in biopsy of muscu­loskeletal soft tissue lesions [10].

33.5 CT-Guided Biopsy

Traditionally, real-time visualization was not possible with CT guidance. However, with the capability of CT uoros­copy, real-time guidance is also possible, albeit with an increased radiation exposure to the patient as well as the operator. The biggest advantage is the superior visualization of the needle and the lesion, which is not hindered by air or bone. The superior spatial and contrast resolution of CT allows a clear depiction of surrounding structures. The learn­ing curve is also steeper than for US-guided biopsies. Its drawbacks are that it is more time-consuming, expensive, and involves the use of ionizing radiation [1].
CT is the preferred modality for guiding percutaneous biopsy of lesions in the lung, mediastinum, retroperitoneum, and bones (Fig.33.5). Once the patient has been positioned (prone for retroperitoneal or spinal lesions; supine, prone or lateral for lung lesions), a limited helical scan of the area of interest is taken. A 3D reconstruction allows planning of the exact puncture site and needle tract. Contrast-enhanced scan may be done in case of isodense lesions, lesions close to ves-
sels, or necrotic lesions to identify the safest site likely to yield viable tissue. The slice in which the lesion is best seen in its longest dimension is chosen. In case cranial or caudal angulation is required in order to get adequate sample from the lesion or to avoid vital structures, the gantry may be tilted appropriately (if the CT machine allows this feature) [11]. This is known as the “triangulation” technique in which an out-of-plane cranial or caudal needle entry is made with an angled approach to avoid critical structures and reach the lesion. This is particularly useful to accurately target upper abdominal lesions in the adrenal, kidney, retroperitoneum, and liver by an extrapleural, extraperitoneal route with low risk of complications such as pneumothorax [12].
An external grid or scale is placed on the skin over the selected slice using the laser beam of the CT gantry. A lim­ited axial scan of 3–5 slices is taken at this site in order to select the needle entry site. Local anesthesia is then instilled at the selected site of needle entry. Based on the planned angle and length of trajectory, the needle is advanced up to a depth of 1–2cm. Another limited scan of 3–5 slices is taken in order to conrm the needle entry site and projected path. The distance from the needle tip to the lesion is measured on the image and the needle is advanced into the lesion. Needle should always be advanced swiftly but gently and the patient may be asked to hold his/her breath while the needle is advanced in order to minimize trauma to surrounding tissue. Once the tip of the needle has been conrmed to be within the lesion on check scan, the inner stylet is removed and the biopsy gun is advanced through it. Another check scan is done after the gun has been advanced completely and then red. Multiple cores are taken in quick succession and placed in formalin solution. If other molecular, immunohistochemi­cal, or genetic tests are planned, the specimen may be placed in separate containers as necessary.
The blunt stylet may be placed in between passes to mini­mize bleeding. The dwell time of the needle in the tissue should be minimized as much as possible to reduce compli­cations. A check scan may be taken prior to removal of the outer cannula in case there is suspicion of bleeding, pneumo­thorax, or needle displacement. Gel foam prepared with iodinated contrast may be injected along the tract in case of bleeding. In case of mild to moderate pneumothorax, the air
abc
Fig. 33.5 CT-guided biopsy. (a) Left adrenal mass sampled by a direct posterior approach with the patient in lateral oblique position. (b) Trans- sternal biopsy of anterior mediastinal mass. (c) Left upper lobe lung mass
420
N. Baijal and S. H. Chandrashekhara
can be aspirated using a three-way cannula, while large pneumothorax with signicant lung collapse requires the placement of a pigtail catheter or intercostal drain. After the procedure, the patient should be instructed to lie with the puncture site in the dependent position so that it is com­pressed by the patient’s body weight. This minimizes local bleeding and also prevents the aspiration of blood into the contralateral lung in case of lung biopsies.
CT uoroscopy is a useful technique as it combines the real-time capability of uoroscopy with the spatial and con­trast resolution of CT.However, this comes at the expense of an increased radiation dose to the patient as well as to the operator. It is most commonly used for percutaneous trans­thoracic biopsy of lung nodules—uoroscopy allows the visualization of a lung nodule as it moves with respiration so that the needle may be positioned within the nodule while sampling. CT uoroscopy has also been used for small liver lesions, especially those near the diaphragm, and for mesen­teric or omental masses that are intermittently surrounded by bowel. It can reduce the procedure time and the number of pleural punctures and avoid hitting the ribs during needle advancement. The various ways to minimize radiation expo­sure during CT uoroscopy include the use of intermittent uoroscopy, low kV and low mA technique, small slice thickness, and use of dedicated needle holders to keep the operator’s hands away from the primary beam. The post­procedure CT can also be done in a low-dose setting to reduce the radiation dose [1, 1315].

33.6 MRI-Guided Biopsy

The use of MRI as a guide for biopsies is limited due to its high cost, long procedure time, limited availability, and the need for MRI-compatible hardware. However, sometimes it may be the only modality in which the lesion is seen, thereby making it the only imaging modality that can be used to guide the biopsy.
The bulk of the MRI gantry and inaccessibility inside the bore limited the use of MRI to guide interventions. However, with the development of wide-bore machines and lighter magnets, accessibility for interventions has improved. With the development of MRI-compatible hardware, open­conguration MRI systems, ultrafast sequences, and MRI uoroscopy, MRI-guided interventions have become more feasible. The advantages of MRI include a superior contrast resolution, the ability to visualize vessels without contrast, multiplanar imaging, and lack of ionizing radiation. It is essential to screen the patient for any contraindications to MRI such as cardiac pacemakers, brainstem implants, metal­lic prostheses, and claustrophobia. Special MR-compatible biopsy devices are required, which do not heat up and show
minimal susceptibility artifacts allowing visualization of the needle.
MRI-guided biopsy is most commonly used in breast lesions that are not seen on mammography and USG.MRI­guided prostate biopsy is also indicated in similar situations when there is high clinical suspicion based on PSA levels, and blind or TRUS-guided biopsy yields negative results. It has been found useful in pediatric and obstetric patients owing to the lack of ionizing radiation. It can also been used for biopsy of bone marrow lesions not seen on any other modality and liver lesions that are poorly delineated on USG or CT or those which are located near the dome of diaphragm [1618].
33.7 Specic Organ Considerations
33.7.1 Head andNeck
FNAC from thyroid nodules and cervical lymph nodes is the most commonly performed procedure. While sampling thy­roid nodules, it must be remembered that the thyroid is a highly vascular organ. Needle dwell time in the thyroid should be minimized in order to prevent contamination of the cells with blood which lowers the yield of FNAC.
Cervical lymph nodes are arranged in chains along the jugular veins and the carotid vessels; therefore, care must be taken not to injure these major vessels when performing a biopsy.
Parotid masses are occasionally sampled; cystic masses are more suited for FNAC.Care must be taken not to injure the facial nerve by keeping the needle parallel to the skin and avoiding deeper trajectories.
CT guidance is used for biopsy of skull base lesions. Topical prilocaine applied 30minutes prior to the procedure helps to reduce the pain and makes the patient more cooperative.
More detailed discussion of biopsies in the head and neck region is done in a separate chapter.
33.7.2 Breast
A detailed discussion on breast interventions is covered in another chapter. Typically, a 14G needle is used and at least 5 cores of 20mm length each are obtained for adequate anal­ysis. The biopsy gun must be kept as parallel to the chest as possible to avoid inadvertent injury to the pectoralis muscle, chest wall and underlying pleura. The internal thoracic artery should be avoided when sampling medial masses. Breast masses tend to slip owing to the hard mass in surrounding soft glandular and fatty tissue. Thus, it is important to immo-
33 Image-Guided Biopsy
421
bilize and support the mass using the ultrasound probe or the operator’s hand. The patient should be instructed not to lift heavy weights or do heavy work using the upper limb for at least 24hours. An ice pack should be placed over the site of the biopsy in order to reduce the pain and swelling.
33.7.3 Lung
Biopsy is indicated for lung nodules, primary or secondary lung masses, and occasionally to characterize diffuse lung disease. While most cases of percutaneous lung biopsy are suited to CT guidance, biopsy of peripheral pleural-based masses can be done under USG guidance. While using USG guidance, color Doppler is helpful in differentiate the hypo­vascular mass from the surrounding atelectatic lung with normal vascularity. Ultrasound guidance has been found to be faster, safer, and more accurate than CT guidance for peripheral lung and pleural lesions >1cm in size [19].
The patient is positioned according to the location of the mass and the planned biopsy tract. It is preferable to position the biopsy-side down by keeping the target lesion and the needle tract below the level of the left atrium. Some basic principles to be followed are that a minimum amount of lung parenchyma must be traversed and ssures, large vessels, and diseased lung tissue (such as bullae, emphysema) should be avoided. For small subpleural lesions, however, the short­est route may not necessarily be the best because of the risk of needle dislodgement from the lung into the pleural space. This occurs due to insufcient lung tissue to provide a stable needle position, leading to an increased risk of pneumotho­rax and necessitating additional pleural punctures. To avoid this, an oblique path with a long transpulmonary route is pre­ferred. This provides more stability and scope for adjustment of the needle course without having to puncture the pleura again [1].
When the lung mass is located more centrally, an attempt must be made to direct the needle parallel to the mediastinal vessels and not toward them, so that they are not injured when the biopsy gun is red. Bronchoscopic biopsy should be considered for central masses that are accessible from major bronchi.
The patient must be asked to hold the breath in mid­expiration while piercing the pleura. Once the needle has pierced the pleura, the rest of the procedure must be com­pleted as fast as possible to minimize pneumothorax and bleeding complications as the needle causes injury to the lung and pleura with each respiratory movement. Similarly, needle removal or exchange should be done during expira­tion. An immediate post-procedure scan is done to look for
chest radiograph is performed after 4 hours to look for a delayed pneumothorax.
Complications of percutaneous lung biopsy may be minor such as pneumothorax not requiring intervention, ground glass opacity around the lesion due to hemorrhage, and tran­sient hemoptysis. Major complications include pneumotho­rax requiring intervention, hemothorax, air embolism, needle tract seeding, and death. While the rate of minor complica­tions is higher with core biopsy, the rate of major complica­tions is similar for both aspiration and core biopsy. Factors affecting the complication rate include needle size, length of traversed lung parenchyma, size and depth of the lesion, and operator experience. Larger needles, especially among aspi­ration needles, longer transpulmonary path, and smaller and deeper lesions are associated with a higher risk of pneumo­thorax and hemoptysis. Another factor that affects the risk of pneumothorax is patient position—lateral decubitus position with the biopsy-side down is considered the safest [2023].
Pleuritic pain is common in the immediate post-procedure period if the pleura has been breached and the patient must be counseled and given analgesics appropriately. Pneumothorax is the most common complication with a reported incidence of 15–38% and the need for chest tube insertion in 5–10% of patients who undergo percutaneous transthoracic lung biopsy. The PEARL approach has been advocated to reduce the risk of pneumothorax. It includes positioning the biopsy-side down, removing the needle dur­ing expiration, using an autologous blood patch seal, rapid rollover, and pleural patching. Biopsy-side down is the posi­tion in which the lesion and the needle tract is below the left atrium. Autologous blood (~10 mL) withdrawn from the patient prior to start of the procedure is injected during nee­dle removal to seal the biopsy tract while the patient is asked to maintain forced expiration. Immediately after needle removal, the patient is rolled into a puncture-site down posi­tion before the check scan [24].
In case pneumothorax does occur, management depends on the amount and timing of pneumothorax. Oxygen is administered by nasal cannula at 4–6L/min and 100% con­centration. If the pneumothorax is detected intra-procedure with the needle still in the lung parenchyma, the parenchy­mal tract is sealed using autologous blood clot and the needle is withdrawn into the pleural space. Immediate manual aspi­ration of the air is done using a three-way connector. After that, 20mL of freshly withdrawn blood is injected into the pleural cavity and the needle is withdrawn in held expiration. For large pneumothorax, it may be necessary to place a pig­tail catheter or intercostal drainage tube. In case a delayed pneumothorax is detected, management depends on the size of the pneumothorax and the clinical status. If the thickness of pneumothorax is <3cm at the apex or<2cm at the hilum, and the patient is asymptomatic, no intervention is required. However, symptomatic or larger pneumothoraces require manual aspiration or drainage tube (at least 10F) placement [24].
422
N. Baijal and S. H. Chandrashekhara
33.7.4 Mediastinum
While CT guidance is most commonly used, USG can be used to biopsy mediastinal masses that are in contact with the chest wall. A direct mediastinal, extrapleural approach is preferred in most cases to reduce the risk of pneumothorax.
The approach depends on the compartment in which the mass is located. For prevascular and visceral compartment masses, anterior suprasternal, parasternal, or trans-sternal approach may be used. If the mass or mediastinal fat is in contact with the anterior chest wall lateral to the sternum, the parasternal approach is used. Care must be taken not to injure the internal thoracic artery. If the lesion is not accessible by parasternal route, the trans-sternal route can be used. This is done exclusively under CT guidance, and can be performed using an 18G needle—a bone biopsy gun is not needed to cross the sternum. If the lesion is located above the level of the aortic arch, the suprasternal approach can be taken. The patient is positioned in semi-recumbent position with pil­lows to support the back and the CT gantry is tilted craniocaudally to allow direct visualization of the needle path. Other techniques for the suprasternal approach include hyperextending the neck, using the triangulation technique, and using ultrasound guidance with a small footprint probe placed in the suprasternal notch.
Paravertebral, subcarinal, and other posterior mediastinal masses are accessed by the paravertebral approach. The patient is laid prone and a salinoma is created using normal saline in order to hydrodissect through the tissues, provide space for the biopsy needle, and avoid traversing the lung.
Sometimes an extrapleural approach may not be possible due to the location and size of the mass. In such cases, tra­versing through the lung may be avoided by advancing the needle through a pre-existing pleural effusion or an iatro­genically created pneumothorax. If no other approach is pos­sible, a transpulmonary approach is used. However, crossing the visceral pleura and lung twice to reach the mediastinal lesion substantially increases the risk of pneumothorax [1,
2527].
33.7.5 Liver
The indications for sampling in diffuse liver disease include identifying the cause of chronic liver disease (CLD), detec­tion of non-alcoholic steatohepatitis (NASH), autoimmune hepatitis (AIH), graft rejection in liver transplant and quanti­cation of liver fat or iron content.
Focal liver lesions can often be diagnosed on multiphase CT or MRI examinations using LIRADS and biopsy is not always required. However, for LR4 and LR-M lesions and
for patients in whom LIRADS cannot be applied, such as children, patients of Budd-Chiari syndrome, and those with known cancer, sampling may be required to prove the nature of the liver lesion.
Image-guided liver biopsy can be done percutaneously or by the transvenous route. Percutaneous biopsy of the liver is most commonly done using USG guidance. CEUS is used to enhance the conspicuity of focal liver lesions and to identify the viable enhancing portion in necrotic lesions in order to improve the diagnostic yield [8, 28]. CT-guided biopsy is done for small focal liver lesions that are poorly visualized on USG due to the patient’s body habitus, location near the dome of diaphragm, intervening ribs, pleura, or bowel gas. An immediate pre-procedure contrast-enhanced scan can be done to improve lesion conspicuity. However, lesions that become isodense to the liver on delayed phases and artifacts from the needle tip may impair the visibility of lesion [29]. MRI-guided biopsy is done for lesions that are poorly seen on both USG and CT, especially those <20 mm in size. MR-guided freehand biopsy of liver lesions has been found to have higher clinical success, lower complication rates, but longer procedure times than CT guidance [30].
The liver is a highly vascular organ and it moves with respiration. In case of liver biopsy for diffuse liver disease, the site with maximum amount of liver parenchyma is cho­sen, avoiding the major vessels and bile ducts. For focal lesions, the approach may be epigastric, subcostal, or inter­costal depending on the location of the lesion. Since capsule is the most pain-sensitive part, adequate local anesthesia is given till the capsule in order to prevent the patient from sud­denly moving when the capsule is pierced. Major vessels including the hepatic veins, main portal vein, and their branches must be avoided as they do not recoil if injured due to the surrounding brous parenchyma. Gel foam “plug” prepared in normal saline should be routinely injected along the biopsy tract till the liver capsule at the end of the proce­dure. The patient must be monitored for the development of ascites (hemoperitoneum) immediately and for up to 4hours after the procedure by ultrasound. Volume redistribution in CLD leads to reduced amount of parenchyma available for sampling, and the development of coagulopathy and ascites as the patient decompensates. In such cases, transvenous route is preferred.
Transjugular liver biopsy (TJLB) is indicated in patients with ascites and/or coagulopathy. It can also be done in cases of failed percutaneous biopsy, morbid obesity, atrophic liver, suspected amyloidosis, cardiac cirrhosis, peliosis hepatis, chronic kidney disease, and hereditary hemorrhagic telangi­ectasia, in which the risk of bleeding is high. The right inter­nal jugular vein (IJV) is the preferred site of access. If the right IJV is thrombosed, alternatives such as left IJV, the